IL145981A0 - Vaccine compositions comprising a polysacharide of streptococcus - Google Patents
Vaccine compositions comprising a polysacharide of streptococcusInfo
- Publication number
- IL145981A0 IL145981A0 IL14598100A IL14598100A IL145981A0 IL 145981 A0 IL145981 A0 IL 145981A0 IL 14598100 A IL14598100 A IL 14598100A IL 14598100 A IL14598100 A IL 14598100A IL 145981 A0 IL145981 A0 IL 145981A0
- Authority
- IL
- Israel
- Prior art keywords
- polysacharide
- streptococcus
- vaccine compositions
- vaccine
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/05—Adjuvants
- C12N2501/056—Immunostimulating oligonucleotides, e.g. CpG
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9909077.1A GB9909077D0 (en) | 1999-04-20 | 1999-04-20 | Novel compositions |
| PCT/EP2000/003514 WO2000062801A2 (en) | 1999-04-20 | 2000-04-17 | Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL145981A0 true IL145981A0 (en) | 2002-07-25 |
Family
ID=10851924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14598100A IL145981A0 (en) | 1999-04-20 | 2000-04-17 | Vaccine compositions comprising a polysacharide of streptococcus |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20040228879A1 (ja) |
| EP (2) | EP1171159B1 (ja) |
| JP (1) | JP2002542204A (ja) |
| KR (1) | KR100632835B1 (ja) |
| CN (1) | CN1192797C (ja) |
| AR (1) | AR023535A1 (ja) |
| AT (1) | ATE395079T1 (ja) |
| AU (1) | AU754101B2 (ja) |
| BR (1) | BR0010682A (ja) |
| CA (1) | CA2365579A1 (ja) |
| CO (1) | CO5300414A1 (ja) |
| CZ (1) | CZ20013773A3 (ja) |
| DE (1) | DE60038877D1 (ja) |
| ES (1) | ES2304960T3 (ja) |
| GB (1) | GB9909077D0 (ja) |
| HK (1) | HK1045100A1 (ja) |
| HU (1) | HUP0201905A3 (ja) |
| IL (1) | IL145981A0 (ja) |
| MY (1) | MY125000A (ja) |
| NO (1) | NO20015074L (ja) |
| NZ (1) | NZ514961A (ja) |
| PL (1) | PL351894A1 (ja) |
| TR (1) | TR200103012T2 (ja) |
| TW (1) | TWI234463B (ja) |
| WO (1) | WO2000062801A2 (ja) |
| ZA (1) | ZA200108620B (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9706957D0 (en) | 1997-04-05 | 1997-05-21 | Smithkline Beecham Plc | Formulation |
| GB9820525D0 (en) | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
| MY125202A (en) * | 1999-03-19 | 2006-07-31 | Smithkline Beecham Biologicals S A | Vaccine |
| GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
| AUPQ761200A0 (en) * | 2000-05-19 | 2000-06-15 | Hunter Immunology Limited | Compositions and methods for treatment of mucosal infections |
| FR2828406B1 (fr) * | 2001-08-08 | 2005-06-24 | Aventis Pasteur | Composition vaccinale bivalente havi |
| IL308456A (en) | 2005-04-08 | 2024-01-01 | Wyeth Llc | A multivalent pneumomuroral protein-polysaccharide conjugate preparation |
| US9839685B2 (en) | 2006-04-13 | 2017-12-12 | The Regents Of The University Of Michigan | Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen |
| TW200806315A (en) | 2006-04-26 | 2008-02-01 | Wyeth Corp | Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
| US8808707B1 (en) | 2006-05-08 | 2014-08-19 | Wyeth Llc | Pneumococcal dosing regimen |
| PL2271360T3 (pl) * | 2008-04-16 | 2016-03-31 | Glaxosmithkline Biologicals Sa | Szczepionka |
| ES2566646T3 (es) * | 2009-06-16 | 2016-04-14 | The Regents Of The University Of Michigan | Vacunas en nanoemulsión |
| SG178904A1 (en) | 2009-09-10 | 2012-04-27 | Novartis Ag | Combination vaccines against respiratory tract diseases |
| CN101703769B (zh) * | 2009-11-13 | 2013-05-08 | 广东永顺生物制药股份有限公司 | 一种新型猪链球菌病四价灭活疫苗 |
| AU2011262346B2 (en) * | 2010-06-04 | 2014-12-11 | Wyeth Llc | Streptococcus pneumoniae vaccine formulations |
| US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
| RU2017120039A (ru) | 2014-12-10 | 2019-01-10 | Дженентек, Инк. | Антитела к рецепторам гематоэнцефалического барьера и способы их применения |
| EP3347042A4 (en) * | 2015-09-10 | 2019-02-20 | Inventprise, LLC. | MULTIVALENT CONJUGATES WITH VIRUSUAL PARTICLES |
| US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
| WO2023218322A1 (en) | 2022-05-11 | 2023-11-16 | Pfizer Inc. | Process for producing of vaccine formulations with preservatives |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235877A (en) | 1979-06-27 | 1980-11-25 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
| US4372945A (en) | 1979-11-13 | 1983-02-08 | Likhite Vilas V | Antigen compounds |
| IL61904A (en) | 1981-01-13 | 1985-07-31 | Yeda Res & Dev | Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same |
| BE889979A (fr) | 1981-08-14 | 1982-02-15 | Smith Kline Rit | Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation |
| US5149650A (en) | 1986-01-14 | 1992-09-22 | University Of North Carolina At Chapel Hill | Vaccines for human respiratory virus |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| KR0137963B1 (ko) | 1987-12-23 | 1998-04-30 | 로버트 에이. 아미테이지 | 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질 |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
| PL170980B1 (pl) | 1992-06-25 | 1997-02-28 | Smithkline Beecham Biolog | Szczepionka PL PL PL PL PL PL PL |
| ES2162139T5 (es) | 1993-03-23 | 2008-05-16 | Smithkline Beecham Biologicals S.A. | Composiciones de vacuna que contienen monofosforil-lipido a 3-o-desacilado. |
| AU676340B2 (en) * | 1993-05-25 | 1997-03-06 | Wyeth Holdings Corporation | Adjuvants for vaccines against respiratory syncytial virus |
| ATE254475T1 (de) | 1993-09-22 | 2003-12-15 | Jackson H M Found Military Med | Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| US6764682B1 (en) * | 1994-06-16 | 2004-07-20 | Aventis Pasteur Limited | Adjuvant compositions containing more than one adjuvant |
| AU713040B2 (en) | 1994-07-15 | 1999-11-18 | University Of Iowa Research Foundation, The | Immunomodulatory oligonucleotides |
| CA2218385A1 (en) * | 1995-04-17 | 1996-10-24 | Pierre Hauser | Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins |
| GB9620795D0 (en) * | 1996-10-05 | 1996-11-20 | Smithkline Beecham Plc | Vaccines |
| UA56132C2 (uk) * | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| AU1146597A (en) * | 1995-12-06 | 1997-06-27 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Compositions and method for stimulating antibody release by b lymphocytes |
| SE9601158D0 (sv) * | 1996-03-26 | 1996-03-26 | Stefan Svenson | Method of producing immunogenic products and vaccines |
| US6020182A (en) * | 1996-07-12 | 2000-02-01 | Connaught Laboratories Limited | Subunit respiratory syncytial virus vaccine preparation |
| WO1998018819A1 (en) * | 1996-10-29 | 1998-05-07 | Smithkline Beecham Biologicals S.A. | Purification of respiratory syncytial virus antigens |
| US6406705B1 (en) * | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| FR2763244B1 (fr) * | 1997-05-14 | 2003-08-01 | Pasteur Merieux Serums Vacc | Composition vaccinale multivalente a porteur mixte |
| GB9712347D0 (en) * | 1997-06-14 | 1997-08-13 | Smithkline Beecham Biolog | Vaccine |
-
1999
- 1999-04-20 GB GBGB9909077.1A patent/GB9909077D0/en not_active Ceased
-
2000
- 2000-04-17 BR BR0010682-8A patent/BR0010682A/pt not_active IP Right Cessation
- 2000-04-17 IL IL14598100A patent/IL145981A0/xx unknown
- 2000-04-17 TR TR2001/03012T patent/TR200103012T2/xx unknown
- 2000-04-17 AT AT00940231T patent/ATE395079T1/de not_active IP Right Cessation
- 2000-04-17 EP EP00940231A patent/EP1171159B1/en not_active Expired - Lifetime
- 2000-04-17 WO PCT/EP2000/003514 patent/WO2000062801A2/en active Search and Examination
- 2000-04-17 DE DE60038877T patent/DE60038877D1/de not_active Expired - Lifetime
- 2000-04-17 CZ CZ20013773A patent/CZ20013773A3/cs unknown
- 2000-04-17 EP EP08151478A patent/EP1927366A1/en not_active Withdrawn
- 2000-04-17 AU AU55233/00A patent/AU754101B2/en not_active Ceased
- 2000-04-17 ES ES00940231T patent/ES2304960T3/es not_active Expired - Lifetime
- 2000-04-17 PL PL00351894A patent/PL351894A1/xx not_active Application Discontinuation
- 2000-04-17 KR KR1020017013365A patent/KR100632835B1/ko not_active IP Right Cessation
- 2000-04-17 HU HU0201905A patent/HUP0201905A3/hu not_active Application Discontinuation
- 2000-04-17 CN CNB00809053XA patent/CN1192797C/zh not_active Expired - Fee Related
- 2000-04-17 JP JP2000611937A patent/JP2002542204A/ja active Pending
- 2000-04-17 CA CA002365579A patent/CA2365579A1/en not_active Abandoned
- 2000-04-17 NZ NZ514961A patent/NZ514961A/en unknown
- 2000-04-18 MY MYPI20001649A patent/MY125000A/en unknown
- 2000-04-18 AR ARP000101808A patent/AR023535A1/es not_active Application Discontinuation
- 2000-04-19 CO CO00028930A patent/CO5300414A1/es not_active Application Discontinuation
- 2000-04-20 TW TW089107452A patent/TWI234463B/zh not_active IP Right Cessation
-
2001
- 2001-10-18 NO NO20015074A patent/NO20015074L/no not_active Application Discontinuation
- 2001-10-19 ZA ZA200108620A patent/ZA200108620B/en unknown
-
2002
- 2002-06-27 HK HK02104796.6A patent/HK1045100A1/zh unknown
-
2004
- 2004-06-15 US US10/867,880 patent/US20040228879A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60038877D1 (de) | 2008-06-26 |
| KR20010110784A (ko) | 2001-12-13 |
| US20040228879A1 (en) | 2004-11-18 |
| HK1045100A1 (zh) | 2002-11-15 |
| AU5523300A (en) | 2000-11-02 |
| EP1171159A2 (en) | 2002-01-16 |
| EP1171159B1 (en) | 2008-05-14 |
| JP2002542204A (ja) | 2002-12-10 |
| PL351894A1 (en) | 2003-06-30 |
| ES2304960T3 (es) | 2008-11-01 |
| HUP0201905A2 (en) | 2002-09-28 |
| NO20015074L (no) | 2001-11-15 |
| AR023535A1 (es) | 2002-09-04 |
| WO2000062801A2 (en) | 2000-10-26 |
| TR200103012T2 (tr) | 2002-06-21 |
| CO5300414A1 (es) | 2003-07-31 |
| AU754101B2 (en) | 2002-11-07 |
| ATE395079T1 (de) | 2008-05-15 |
| TWI234463B (en) | 2005-06-21 |
| MY125000A (en) | 2006-07-31 |
| BR0010682A (pt) | 2002-02-05 |
| WO2000062801A3 (en) | 2001-01-11 |
| CN1192797C (zh) | 2005-03-16 |
| EP1927366A1 (en) | 2008-06-04 |
| NO20015074D0 (no) | 2001-10-18 |
| NZ514961A (en) | 2003-08-29 |
| ZA200108620B (en) | 2002-09-13 |
| CN1355710A (zh) | 2002-06-26 |
| HUP0201905A3 (en) | 2003-12-29 |
| CZ20013773A3 (cs) | 2002-05-15 |
| KR100632835B1 (ko) | 2006-10-16 |
| GB9909077D0 (en) | 1999-06-16 |
| CA2365579A1 (en) | 2000-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL145981A0 (en) | Vaccine compositions comprising a polysacharide of streptococcus | |
| HUS1500040I1 (hu) | Sztreptokokkusz oltóanyag | |
| IL148456A0 (en) | Combined vaccine compositions | |
| HK1105581A1 (en) | Vaccine composition | |
| PL343429A1 (en) | Combined vaccine compositions | |
| GB9806456D0 (en) | Vaccine composition | |
| HK1044476A1 (en) | Medicinal compositions | |
| PL354575A1 (en) | Antiperspirant compositions | |
| IL148247A (en) | Vaccine and its uses | |
| PL351147A1 (en) | Antiperspirant compositions | |
| EP1166786A4 (en) | MEDICAL COMPOSITIONS | |
| PL352963A1 (en) | Antiperspirant compositions | |
| GB9908218D0 (en) | Antiperspirant compositions | |
| HK1045856A1 (zh) | 抗細菌疫苗組合物 | |
| GB9923045D0 (en) | New oral formulations | |
| HUP9801705A3 (en) | Streptococcus equi vaccine | |
| GB9801870D0 (en) | Vaccine composition | |
| AU1101701A (en) | Vaccine compositions | |
| GB9921347D0 (en) | Novel immunogenic compositions | |
| GB9911823D0 (en) | New vaccine formulations | |
| GB9929434D0 (en) | Novel vaccine composition | |
| GB9930461D0 (en) | Vaccine compositions | |
| GB9930459D0 (en) | Vaccine compositions | |
| GB9930458D0 (en) | Vaccine compositions | |
| GB9930456D0 (en) | Vaccine compositions |